BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 25393703)

  • 1. ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.
    Baarine M; Beeson C; Singh A; Singh I
    J Neurochem; 2015 May; 133(3):380-96. PubMed ID: 25393703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.
    Singh J; Khan M; Singh I
    J Lipid Res; 2011 Nov; 52(11):2056-69. PubMed ID: 21891797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophy-associated very long-chain fatty acids target several cellular energy-dependent functions.
    Kruska N; Schönfeld P; Pujol A; Reiser G
    Biochim Biophys Acta; 2015 May; 1852(5):925-36. PubMed ID: 25583114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
    Singh J; Olle B; Suhail H; Felicella MM; Giri S
    J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of oxidative stress in very long chain fatty acid--treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins.
    Baarine M; Andréoletti P; Athias A; Nury T; Zarrouk A; Ragot K; Vejux A; Riedinger JM; Kattan Z; Bessede G; Trompier D; Savary S; Cherkaoui-Malki M; Lizard G
    Neuroscience; 2012 Jun; 213():1-18. PubMed ID: 22521832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction.
    Wiesinger C; Kunze M; Regelsberger G; Forss-Petter S; Berger J
    J Biol Chem; 2013 Jun; 288(26):19269-79. PubMed ID: 23671276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy.
    López-Erauskin J; Galino J; Ruiz M; Cuezva JM; Fabregat I; Cacabelos D; Boada J; Martínez J; Ferrer I; Pamplona R; Villarroya F; Portero-Otín M; Fourcade S; Pujol A
    Hum Mol Genet; 2013 Aug; 22(16):3296-305. PubMed ID: 23604518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Abcd1 level on the induction of cell death and organelle dysfunctions triggered by very long chain fatty acids and TNF-α on oligodendrocytes and astrocytes.
    Baarine M; Ragot K; Athias A; Nury T; Kattan Z; Genin EC; Andreoletti P; Ménétrier F; Riedinger JM; Bardou M; Lizard G
    Neurotoxicology; 2012 Mar; 33(2):212-28. PubMed ID: 22057157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeic acid phenethyl ester induces adrenoleukodystrophy (Abcd2) gene in human X-ALD fibroblasts and inhibits the proinflammatory response in Abcd1/2 silenced mouse primary astrocytes.
    Singh J; Khan M; Singh I
    Biochim Biophys Acta; 2013 Apr; 1831(4):747-58. PubMed ID: 23318275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment.
    Kemp S; Wanders RJ
    Mol Genet Metab; 2007 Mar; 90(3):268-76. PubMed ID: 17092750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
    McGuinness MC; Zhang HP; Smith KD
    Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical aspects of X-linked adrenoleukodystrophy.
    Kemp S; Wanders R
    Brain Pathol; 2010 Jul; 20(4):831-7. PubMed ID: 20626744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitor upregulates peroxisomal fatty acid oxidation and inhibits apoptotic cell death in abcd1-deficient glial cells.
    Singh J; Khan M; Pujol A; Baarine M; Singh I
    PLoS One; 2013; 8(7):e70712. PubMed ID: 23923017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy.
    McGuinness MC; Lu JF; Zhang HP; Dong GX; Heinzer AK; Watkins PA; Powers J; Smith KD
    Mol Cell Biol; 2003 Jan; 23(2):744-53. PubMed ID: 12509471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiency.
    Oezen I; Rossmanith W; Forss-Petter S; Kemp S; Voigtländer T; Moser-Thier K; Wanders RJ; Bittner RE; Berger J
    Hum Mol Genet; 2005 May; 14(9):1127-37. PubMed ID: 15772093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A zebrafish model of X-linked adrenoleukodystrophy recapitulates key disease features and demonstrates a developmental requirement for abcd1 in oligodendrocyte patterning and myelination.
    Strachan LR; Stevenson TJ; Freshner B; Keefe MD; Miranda Bowles D; Bonkowsky JL
    Hum Mol Genet; 2017 Sep; 26(18):3600-3614. PubMed ID: 28911205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy.
    Weinhofer I; Forss-Petter S; Zigman M; Berger J
    Hum Mol Genet; 2002 Oct; 11(22):2701-8. PubMed ID: 12374760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of Abcd1 and Abcd2 genes sensitizes astrocytes for inflammation: implication for X-adrenoleukodystrophy.
    Singh J; Khan M; Singh I
    J Lipid Res; 2009 Jan; 50(1):135-47. PubMed ID: 18723473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation.
    Engelen M; Schackmann MJ; Ofman R; Sanders RJ; Dijkstra IM; Houten SM; Fourcade S; Pujol A; Poll-The BT; Wanders RJ; Kemp S
    J Inherit Metab Dis; 2012 Nov; 35(6):1137-45. PubMed ID: 22447153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Thyroid Hormone-Based Strategy for Correcting the Biochemical Abnormality in X-Linked Adrenoleukodystrophy.
    Hartley MD; Kirkemo LL; Banerji T; Scanlan TS
    Endocrinology; 2017 May; 158(5):1328-1338. PubMed ID: 28200172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.